These data support a scenario where the loss of STRIP1, and the subsequent activation of MST3&4, can create a heterogeneous subpopulation of cells expressing high levels of p21 and p27 within an isogenic population of breast cancer cells. This evidence concerns the gene CDKN1B and breast cancer.